Antitumor activity of actinonin in vitro and in vivo

Clinical Cancer Research

Volumn 4, Issue 1, 1998, Pages 171-176

  Xu, Yang ^a   Lai, Lawrence T ^a   Gabrilove, Janice L ^a   Scheinberg, David A ^a,b  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTINONIN; AMASTATIN; ANTIBIOTIC AGENT; ANTINEOPLASTIC AGENT; BESTATIN; CD11B ANTIGEN; ENZYME INHIBITOR; INTERLEUKIN 3; LEUCINE; MICROSOMAL AMINOPEPTIDASE; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY F23; PROTEIN BCL 2; THYMIDINE; TRITIUM; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CELL CYCLE; CELL STRAIN HL 60; CONTROLLED STUDY; CYTOTOXICITY; DAUDI CELL; DOSE RESPONSE; FEMALE; GROWTH INHIBITION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; INTRAPERITONEAL DRUG ADMINISTRATION; LEUKEMIA CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN SYNTHESIS INHIBITION; SURVIVAL;

ANIMALS; ANTIBIOTICS, ANTINEOPLASTIC; APOPTOSIS; BONE MARROW CELLS; FEMALE; G1 PHASE; HUMANS; HYDROXAMIC ACIDS; LEUKEMIA, EXPERIMENTAL; MICE; MICE, INBRED AKR; TUMOR CELLS, CULTURED;

EID: 0031930519     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Shipp, M. A., and Look, A. T. Hematopoietic differentiation antigens that are membrane-associated enzymes: cutting is the key! Blood, 82: 1052-1070, 1993.
2. Delmas, B., Gelfi, J., L'Haridon, R., Vogel, L. K., Sjostrom, H., Noren, O., and Laude, H. Aminopeptidase N is a major receptor for the enteropathogenic coronavirus TGEV. Nature (Lond.), 357: 417-420, 1992.
3. Yeager, C. L., Ashmun, R. A., Williams, R. K., Cardellichio, C. B., Shapiro, L. H., Look, A. T., and Holmes, K. V. Human aminopeptidase N is a receptor for human coronavirus 229E. Nature (Lond.), 357: 420-422, 1992.
4. Menrad, A., Speicher, D., Wacker, J., and Herlyn, M. Biochemical and functional characterization of aminopeptidase N expressed by human melanoma cells. Cancer Res., 53: 1450-1455, 1993.
5. Saiki, I., Fujii, H., Yoneda, J., Abe, F., Nakajima, M., Tsuruo, T., and Azuma, I. Role of aminopeptidase N (CD13) in tumor-cell invasion and extracellular matrix degradation. Int. J. Cancer, 54: 137-143, 1993.
6. Olsen, J., Cowell, G. M., Konigshofer, E., Danielsen, E. M., Moller, J., Laustsen, L., Hansen, O. C., Welinder, K. G., Engberg, J., Hunziker, W., Spiess, M., Sjostrom, H., and Noren, O. Complete amino acid sequence of human intestinal aminopeptidase N as deduced from cloned cDNA. FEBS Lett., 238: 307-314, 1988.
7. Look, A. T., Ashmun, R. A., Shapiro, L. H., and Peiper, S. C. Human myeloid plasma membrane glycoprotein CD13 (gp150) is identical to aminopeptidase N. J. Clin. Invest., 83: 1299-1307, 1989.
8. Griffin, J. D., Ritz, J., Nadler, L. M., and Schlossman, S. F. Expression of myeloid differentiation antigens on normal and malignant myeloid cells. J. Clin. Invest., 68: 932-941, 1981.
9. Xu, Y., Wellner, D., and Scheinberg, D. A. Substance P and bradykinin are natural inhibitors of CD13/aminopeptidase N. Biochem. Biophys. Res. Commun., 208: 664-674, 1995.
10. Tsuruo, T., Naganuma, K., Iida, H., Yamori, T., Tsukagoshi, S., and Sakurai, Y. Inhibition of lymph node metastasis of P388 leukemia by bestatin in mice. J. Antibiot. (Tokyo), 34: 1206-1209, 1981.
11. Ikeda, S., Miyasato, H., Saito, K., Nakayama, H., and Tajima, K. Phase I study of bestatin: (II) clinical trial of bestatin in malignant skin tumors. In: H. Umezawa (ed.), Small Molecular Immunomodifiers of Microbial Origin, pp. 143-158, Elmsford, NY: Pergamon Press, 1981.
12. Inuyama, Y., Noriuchi, M., Kohno, N., and Mashino, S. Clinical experience with bestatin in head and neck cancer. In: H. Umezawa (ed.), Small Molecular Immunomodifiers of Microbial Origin, pp. 179-186. Elmsford, NY: Pergamon Press, 1981.
13. Isono, K., Onoda, S., Ishikawa, T., Koide, Y., and Sato, H. Clinical and experimental study of bestatin for esophageal cancer. In: H. Umezawa (ed.), Small Molecular Immunomodifiers of Microbial Origin, pp. 187-200. Elmsford, NY: Pergamon Press, 1981.
14. Akiya, K., and Okabe, K. Clinical effect of bestatin on malignant tumors of female genital organs, in: H. Umezawa (ed.), Small Molecular Immunomodifiers of Microbial Origin, pp. 201-210. Elmsford, NY: Pergamon Press, 1981.
15. Abe, F., Schneider, M., Black, P. L., and Talmadge, J. E. Chemoimmunotherapy with cyclophosphamide and bestatin in experimental metastasis in mice. Cancer Immunol. Immunother., 29: 231-236, 1989.
16. Gordon, J. J., Kelly, B. K., and Miller, G. A. Actinonin an antibiotic substance produced by an actinomycete. Nature (Lond.), 195: 701-702, 1962.
17. Gabrilove, J. L., White, K., Rahman, Z., and Wilson, E. L. Stem cell factor and basic fibroblast growth factor are synergistic in augmenting committed myeloid progenitor cell growth. Blood, 83: 907-910, 1994.
18. Xu, Y., Wellner, D., and Scheinberg, D. A. Cryptic and regulatory epitopes in CD13/aminopeptidase N. Exp. Hematol., 25: 521-529, 1997.
19. Xu, Y., Lai, L. T., and Scheinberg, D. A. Actinonin-induced growth arrest and apoptosis in human leukemia cells is associated with p53 modulation but not with aminopeptidase inhibition. Proc. Am. Assoc. Cancer Res., 38: 1368, 1997.
20. Ota, K., and Uzuka, Y. Clinical trials of bestatin for leukemia and solid tumors. Biotherapy, 4: 205-214, 1992.
21. Vallee, B. L., and Auld, D. S. Zinc coordination, function, and structure of zinc enzymes and other proteins. Biochemistry, 29: 5647-5659, 1990.
22. Byrnes, R. W. Inhibition of hydroperoxide-induced DNA single-strand breakage by 1,10-phenanthroline in HL-60 cells implications for iron speciation. Arch. Biochem. Biophys., 332: 70-78, 1996.
23. Urabe, A., Mutoh, Y., Mizoguchi, H., Takaku, F., and Ogawa, N. Ubenimex in the treatment of acute nonlymphocytic leukemia in adults. Ann. Hematol., 67: 63-66, 1993.
24. Ota, K., Kurita, S., Yamada, K., Masaoka, T., Uzuka, Y., and Ogawa, N. Immunotherapy with bestatin for acute nonlymphocytic leukemia in adults. Cancer Immunol. Immunother., 23: 5-10, 1986.
25. Takeuchi, T. Antitumor antibiotics discovered and studied at the Institute of Microbial Chemistry. J. Cancer Res. Clin. Oncol., 121: 505-510, 1995.
26. Talmadge, J. E., Ino, K., Walker, S., Heimann, D., and Bierman, P. Immune augmentation by an orally active peptide following transplantation for lymphoma. Proc. Am. Assoc. Cancer Res., 37: 3340, 1996.
27. Inoi, K., Goto, S., Nomura, S., Isobe, K., Nawa, A., Okamoto, T., and Tomoda, Y. Aminopeptidase inhibitor ubenimex (bestatin) inhibits the growth of human choriocarcinoma in nude mice through its direct cytostatic activity. Anticancer Res., 15: 2081-2087, 1995.
28. Talmadge, J. E., Lenz, B. F., Pennington, R., Long, C., Phillips, H., Schneider, M., and Tribble, H. Immunomodulatory and therapeutic properties of bestatin in mice. Cancer Res., 46: 4505-4510, 1986.